Save the Date! 

When: Monday, October 22, 2018, 12:00 – 1:30 pm
Where: Hyatt Regency, Reston, Virginia (also available via webcast)


Press Briefing on Recent Clinical and Preclinical Advances in Focused Ultrasound

Revolutionary Noninvasive Therapy Shows Promise for Immunotherapy and Opening Blood-brain Barrier to Enable Treatment of Neurological Disease and Cancer

A press briefing will be held at the 6th International Symposium on Focused Ultrasound featuring the most recent advances and emerging applications of focused ultrasound. Global experts will highlight the use of focused ultrasound – a non-invasive, therapeutic, game-changing, disruptive technology – in cancer immunotherapy and for opening the blood-brain barrier to enable passage of drugs to treat neurologic conditions and diseases such as Alzheimer’s, Parkinson’s and glioblastoma.  

The event will be webcast for those unable to attend in person; details to come.

Featured speakers include:

  • Nathan McDannold, PhD: Associate Professor, Radiology, Harvard Medical School and Brigham And Women's Hospital
  • Nir Lipsman, MD, PhD: Neurosurgeon, Sunnybrook Health Sciences Centre
  • Jill O’Donnell-Tormey, PhD: Chief Executive Officer and Director of Scientific Affairs, Cancer Research Institute
  • Katherine Ferrara, PhD: Distinguished Professor of Biomedical Engineering,  University of California, Davis
  • David Brenin, MD: Chief of Breast Surgery, University of Virginia

The Symposium is the world's leading forum for sharing the latest in image-guided focused ultrasound. The four-day event spotlights breakthrough preclinical, translational and clinical research related to one of today’s most promising and innovative therapeutic technologies.

About Focused Ultrasound
Focused ultrasound uses ultrasound energy guided by real-time imaging to treat tissue deep in the body without incisions or radiation. The fundamental principle is analogous to using a magnifying glass to focus beams of sunlight on a single point to burn a hole in a leaf. Where each individual beam passes through the tissue, there is no effect. But, at the focal point, the convergence of the multiple beams of focused ultrasound energy results in many important biological effects, creating the possibility of treating a variety of medical disorders. Focused ultrasound is approved in the United States to treat essential tremor, uterine fibroids, pain from bone metastases, and the prostate. Additional indications are approved outside of the US. The technology is in various stages of research and development for more than 100 diseases, including Alzheimer’s disease, Parkinson’s disease, hypertension, and tumors of the brain, liver, breast, and pancreas.      

Meeting Link: 6th International Symposium on Focused Ultrasound